How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fosfomycin-tromethamine-granules.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Fosfomycin Tromethamine Granules — Competitive Intelligence Brief

Fosfomycin Tromethamine Granules (Fosfomycin Tromethamine Granules) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibiotic (phosphonic acid derivative). Area: Infectious Disease.

phase 3 Antibiotic (phosphonic acid derivative) MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Fosfomycin Tromethamine Granules (Fosfomycin Tromethamine Granules) — Benova (Tianjin) Innovative medicine Research Co., Ltd.. Fosfomycin inhibits bacterial cell wall synthesis by inactivating the enzyme enolpyruvate transferase, preventing peptidoglycan cross-linking.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Fosfomycin Tromethamine Granules TARGET	Fosfomycin Tromethamine Granules	Benova (Tianjin) Innovative medicine Research Co., Ltd.	phase 3	Antibiotic (phosphonic acid derivative)	MurA (UDP-N-acetylglucosamine enolpyruvyl transferase)
Placebo to Fosfomycin	Placebo to Fosfomycin	University Medical Center Goettingen	marketed	Antibiotic (phosphonic acid derivative)	MurA (UDP-N-acetylglucosamine enolpyruvyl transferase)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibiotic (phosphonic acid derivative) class)

Benova (Tianjin) Innovative medicine Research Co., Ltd. · 1 drug in this class
University Medical Center Goettingen · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fosfomycin Tromethamine Granules — Competitive Intelligence Brief. https://druglandscape.com/ci/fosfomycin-tromethamine-granules. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab